Showing results (1-10 of 167) with videos related to
Sort By:
Pageof 17
Expert Review of Hematology|May 9, 2018
Use of acalabrutinib in patients with mantle cell lymphomaFarrukh T Awan, Wojciech JurczakScientific Reports|July 29, 2025
Influence of surface quality on corrosion resistance of stainless steel and aluminum alloy butt welds after innovative finishingOlga Łastowska, Wojciech Jurczak, Robert StarostaExpert Review of Clinical Immunology|February 26, 2019
Avatrombopag for the treatment of immune thrombocytopeniaMonika Długosz-Danecka, Joanna Zdziarska, Wojciech JurczakExpert Opinion on Biological Therapy|September 13, 2019
Rituximab biosimilars for lymphoma in EuropeWojciech Jurczak, Monika Długosz Danecka, Christian BuskeExpert Review of Clinical Pharmacology|January 15, 2019
Acalabrutinib for adults with mantle cell lymphomaWojciech Jurczak, Monika Długosz-Danecka, Michael WangPostepy Higieny I Medycyny Doswiadczalnej (Online)|January 25, 2007
[New trends in non-Hodgkin's lymphoma therapy]Grzegorz Mazur, Tomasz Wróbel, Wojciech Jurczak, et al.Materials (Basel, Switzerland)|February 15, 2022
Static and Dynamic Properties of Al-Mg Alloys Subjected to Hydrostatic ExtrusionWojciech Jurczak, Tomasz Trzepieciński, Andrzej Kubit, et al.Contemporary Oncology (Poznan, Poland)|October 1, 2016
Primary mediastinal B-cell lymphoma - metabolic and anatomical features in 18FDG-PET/CT and response to therapyAnna Kocurek, Bogdan Małkowski, Agnieszka Giza, et al.Future Oncology (London, England)|October 4, 2018
The rationale for combination therapy in patients with aggressive B-cell non-Hodgkin lymphoma: ten questionsWojciech Jurczak, Monika Długosz-Danecka, Fernando Rivas NavarroExpert Opinion on Biological Therapy|February 8, 2021
Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphomaGilles Salles, Monika Długosz-Danecka, Hervé Ghesquières, et al.Pageof 17